Safety and Efficacy of Convalescent Plasma for Severe COVID-19: Interim Report of a Multicenter Phase II Study from Saudi Arabia.

Autor: AlShehry N; Department of Adult Hematology/BMT and, King Fahad Medical City, Riyadh, Saudi Arabia., Zaidi SZA; Department of Adult Hematology/BMT and, King Fahad Medical City, Riyadh, Saudi Arabia., AlAskar A; King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Ministry of National Guard - Heath Affairs, Riyadh, Saudi Arabia., Al Odayani A; Department of Infection Control and Prevention, Prince Sultan Military Medical City, Riyadh, Saudi Arabia., Alotaibi JM; Department of Infectious Diseases, Riyadh, Saudi Arabia., AlSagheir A; Department of Hematology and Oncology, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia., Al-Eyadhy A; Department of Pediatrics, College of Medicine, Riyadh, Saudi Arabia., Balelah S; Department of Medicine, King Fahad General Hospital, Madinah, Saudi Arabia., Salam A; Department of Epidemiology and Biostatistics, King Fahad General Hospital, Dammam, Saudi Arabia., Zaidi ARZ; Department of Medicine, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.; Medical Specialties, King Fahad Medical City, Riyadh, Saudi Arabia.; Research Center, Dr. Sulaiman Al Habib Medical Group, Riyadh, Saudi Arabia., Alawami D; Department of Hematology and Stem Cell Transplantation, King Fahad Specialist Hospital, Dammam, Saudi Arabia., Alshahrani MS; Department of Emergency and Critical Care, College of Medicine, Imam Abdulrahman Bin Faisal University, King Fahd Hospital of the University, Al Khobar, Saudi Arabia., AlMozain N; Department of Blood Bank, College of Medicine, King Saud University, Riyadh, Saudi Arabia.; Division of Hematology, Department of Pathology, King Saud University, Riyadh, Saudi Arabia., Abulhamayel YM; Department of Infectious Diseases, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia., Al Qunfoidi R; Department of Medicine, International Medical Center, Jeddah, Saudi Arabia., Alfaraj M; Hematology Laboratory Section of Medical Laboratory Department, Qatif Central Hospital, Qatif, Saudi Arabia., Qushmaq N; Department of Hematology, King Abdullah Medical Complex, Jeddah, Saudi Arabia., Alansari R; Division of Hematology, Department of Medicine, King Fahd Military Medical Complex, Dhahran, Saudi Arabia., Dayel A; Department of Hematopathology, King Fahad Specialist Hospital, Dammam, Saudi Arabia., Elgohary G; Division of Hematology, Department of Pathology, King Saud University, Riyadh, Saudi Arabia.; Oncology Center, King Saud University Medical City, Riyadh, Saudi Arabia., Al Bahrani A; Department of Transfusion Medicine and Stem Cell Processing, King Fahad Specialist Hospital, Dammam, Saudi Arabia., Nabhan Abdelhameed AA; Internal Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, King Fahd Hospital of the University, Al Khobar, Saudi Arabia., AlZahrani HA; Department of Hematology and Bone Marrow Transplantation, Riyadh, Saudi Arabia., Alturkistani H; Department of Infectious Diseases, King Abdullah Medical City, Makkah, Saudi Arabia., AlShehry N; Department of Infectious Diseases, Asir Central Hospital, Abha, Saudi Arabia., Albalawi MA; Department of Internal Medicine, Taibah University, Madinah, Saudi Arabia., Elalfy I; Department of Critical Care, Dammam Medical Complex, Dammam, Saudi Arabia., Alhumaidan H; Pathology and Laboratory Medicine King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia., Al-Hashmi H; Department of Hematology and Stem Cell Transplantation, King Fahad Specialist Hospital, Dammam, Saudi Arabia.

Publikováno v: Saudi journal of medicine & medical sciences [Saudi J Med Med Sci] 2021 Jan-Apr; Vol. 9 (1), pp. 16-23. Date of Electronic Publication: 2020 Dec 26.